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Current models of HIV-1 morphogenesis hold that
newlysynthesizedviralGagpolyproteins traffic toand
assemble at the cell membrane into spherical protein
shells. The resulting late-budding structure is thought
to be released by the cellular ESCRT machinery sev-
ering the membrane tether connecting it to the pro-
ducer cell. Using electron tomography and scanning
transmission electron microscopy, we find that vi-
rions have a morphology and composition distinct
from late-budding sites. Gag is arranged as a contin-
uous but incomplete sphere in the released virion. In
contrast, late-budding sites lacking functional ESCRT
exhibited a nearly closed Gag sphere. The results
lead us to propose that budding is initiated by Gag
assembly, but is completed in an ESCRT-dependent
manner before the Gag sphere is complete. This sug-
gests that ESCRT functions early in HIV-1 release—
akin to its role in vesicle formation—and is not re-
stricted to severing the thin membrane tether.
INTRODUCTION
HIV-1 assembly and budding are directed by viral Gag polypro-
teins, which are thought to assemble at the cell membrane into
a spherical protein shell, coincident with the induction of
membrane curvature (Demirov and Freed, 2004; Morita and
Sundquist, 2004). Once the spherical Gag shell is complete, the
resulting late-budding structure (appearing like a lollipop in elec-
tron microscopy [EM] sections) is thought to be released by the
cellular ESCRT machinery severing the thin membrane tether
that connects it to the producer cell. ESCRT is recruited by a
PTAP motif in the HIV-1 Gag polyprotein and consists of several
large multiprotein assemblies (ESCRT-I, -II, and -III). Gag binds
the ESCRT-I component TSG101, while the actual release is
thought to be mediated by ESCRT-III, which is disassembled
by the VPS4 ATPase during this process (Hurley, 2008; Morita
and Sundquist, 2004; Williams and Urbe, 2007).592 Cell Host & Microbe 4, 592–599, December 11, 2008 ª2008 ElsHIV-1 is initially released as an immature, noninfectious parti-
cle comprised of a layer of uncleaved Gag polyproteins under-
neath the virion membrane. Subsequently, it is converted into the
mature, infectious virion by the viral protease cleaving Gag in five
distinct positions (Adamson and Freed, 2007). Based on the
hexagonal symmetry and measured center-to-center spacing of
8 nm for the immature lattice, it was suggested that an immature
HIV-1 particle with an average radius of 73 nm consists of 4900
Gag polyproteins arranged in a spherical layer underneath the
virion membrane (Briggs et al., 2004). Since formation of the ma-
ture capsid requires only 1200–1500 CA proteins (derived in stoi-
chiometric amounts by proteolytic cleavage of Gag), not all of the
Gag molecules appear to be needed for the internal structure
of the infectious virion. The presence of surplus CA in mature
HIV-1 was supported by hydrogen-deuterium exchange experi-
ments revealing two roughly equal CA populations with different
exchange rates (Lanman et al., 2004).
Recently, Wright et al. studied immature HIV-1 particles using
cryo-electron tomography (cryo-ET) (Wright et al., 2007). This
method permits analysis of the entire three-dimensional structure
by reconstructing a three-dimensional volume (tomogram) from
a series of tilted projection images of native, frozen particles
(Lucic et al., 2005). The cryo-ET study confirmed the overall ar-
rangement and lattice of the Gag layer, but the authors reported
this layer to be incomplete, covering roughly 40% of the inner
membrane surface. Completeness of the Gag lattice had not
been determined in previous ultrastructural studies because of
the inherent limitations of sectioned preparations and projection
images. Wright et al. also reported that ordered Gag patches in
the virion were arranged in an irregular pattern, separated by large
regions without ordered density. This observation suggested that
HIV-1 budding may occur by the concerted action of multiple Gag
patches rather than a continuous Gag lattice, while such struc-
tures have not been detected in previous ultrastructural studies.
However,no tomographic analysisof HIV-1 budding siteshas been
reported to date, and accordingly, no complete three-dimensional
reconstruction of viral budding sites is available.
Here, we present three-dimensional structural data on HIV-1
budding sites and released immature virions, obtained by elec-
tron tomography along with scanning transmission electron mi-
croscopy (STEM) mass measurements of immature and mature
virions. The results lead us to propose that HIV-1 budding isevier Inc.
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radius of curvature early in assembly, but is completed in an
ESCRT-dependent manner well before the Gag shell is complete.
Accordingly, extracellular particles contain an incomplete but
continuous Gag layer covering approximately two-thirds of the
virion membrane. These findings suggest that ESCRT acts much
earlier in HIV-1 release—akin to its role in vesicle formation,
where it is involved at all stages—and its function is not restricted
to severing the thin membrane tether of the completed late bud.
The observed late-budding structures may thus represent as-
sembly complexes lacking a functional ESCRT machinery where
Gag can reach its equilibrium assemblage, but do not appear to
be normal precursors of extracellular HIV-1.
Figure 1. Gag Organizes as a Truncated
Sphere in Cryo-Electron Tomograms of Im-
mature HIV-1
(A–E) Four computational slices through a cryo-
electron tomogram of an immature HIV-1 particle
are shown (A–D, top) along with a surface model
showing the position of the slices in the 3D volume.
The slices are 2 nm thick and placed 20 nm apart.
The membrane is depicted in light blue, Gag in
red. Scale bars are 100 nm.
RESULTS
The Gag Layer in Immature HIV-1
Particles
Immature HIV-1 particles were produced
in infected MT-4 cells cultured in the pres-
ence of a specific inhibitor of the viral
protease, and complete inhibition of Gag
processing was verified on silver stained
gels (Figure S1). Purified particles were
vitrified by plunge-freezing into liquid eth-
ane and subjected to cryo-ET. Nine tilt
series were recorded on two independent
virus preparations. From visual inspection
of the resulting tomograms, the Gag den-
sity appeared as one continuous Gag
layer in each virion, typically covering be-
tween half and roughly three-quarters of
the membrane surface (see Movie S1).
Figure 1 shows a rendering of a typical
particle and sections through different
parts of the virion. The Gag lattice appears
complete at the top (Figure 1A) while be-
ing clearly incomplete at the center
(Figure 1C) and lower part (Figure 1D) of
the same particle. Thirty virions recon-
structed with sufficient quality were se-
lected for further quantitative analysis.
Since the Gag layer appeared continu-
ous in all reconstructions, its closure can
be described by an angle ranging from
0 to 360, with 180 representing a half sphere and 360 repre-
senting a closed sphere (Figure 2A). The average closure of the
30 selected immature virions was 229 ± 35 (equivalent to a
completeness of 70% ± 13%) (Table 1 and Figure 2A). No parti-
cles with a Gag layer closure >300 were detected. Knowing the
closure and radius of the Gag layer, its area can be derived. The
lattice arrangement and spacing of the immature Gag lattice has
been measured (Briggs et al., 2004), providing the number of Gag
proteins that are required to cover a given area of membrane.
The resulting number of Gag proteins per virion is highly depen-
dent on the particle diameter, and HIV-1 sizes were found to be
variable in different preparations. A virus of 73 nm radius with a
complete Gag shell would thus contain 4900 Gag proteins, asCell Host & Microbe 4, 592–599, December 11, 2008 ª2008 Elsevier Inc. 593
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A Revised Model for HIV-1 MorphogenesisFigure 2. The Gag Layer Is Less Closed in Released Virions Than in Late-Budding Sites
(A–C) Gag closure measurements for released immature particles (A), cellular budding sites from the release competent (B), and budding arrested groups (C) (see
Table 3 for constructs used).
(D) The radius of the bud (from the center to the plasma membrane) was plotted against the closure of the Gag layer for the 27 fully contained buds from the
budding arrested group. The radius of curvature was similar in early and late buds. A closure of 180 corresponds to a half-sphere and 360 to a full sphere,
as depicted underneath the panels.reported in our previous study (Briggs et al., 2004). If the Gag
layer is only 70% complete, 3500 Gag proteins would be re-
quired for a virus with the same radius. The 30 HIV-1 particles
measured here had a radius of 63 ± 5 nm, corresponding to an
average Gag content of 2400 ± 700 molecules for a 70% com-
plete Gag shell (Table 1). To confirm that the incomplete Gag
shell is a not a specific feature of virions produced from MT4
cells, we also performed cryo-ET on immature virions purified
from HeLa cells transfected with a complete HIV-1 proviral
plasmid. These cells produce lower amounts of HIV-1, but the
purified virions exhibited a similarly incomplete Gag lattice
(Movies S2 and S3).
As an independent complementary approach, mass measure-
ments of individual immature and mature HIV-1 virions were per-
formed using STEM. This technique permits the mass determi-
nation of individual freeze-dried particles (Vogt and Simon,
1999; Wall et al., 1998). Tobacco mosaic virus (TMV) was ana-
lyzed in the same preparations to calibrate all measurements.
Parallel HIV-1 preparations were produced in MT-4 cells in the
presence and absence of a specific HIV protease inhibitor, and
the purified virus was inactivated with either paraformaldehyde
(PFA) or 2-aldrithiol (AT-2) (Rossio et al., 1998). Since the mode
of inactivation had no significant influence on virus mass (Table
2), the data sets were pooled. The TMV-corrected mass for ma-
ture HIV-1 was 276 ± 88 MDa (n = 258) and for immature HIV-1
was 281 ± 82 MDa (n = 84) (Table 2). Thus, the mass (and pre-
sumably Gag content) of immature and mature HIV-1 was not594 Cell Host & Microbe 4, 592–599, December 11, 2008 ª2008 Elssignificantly different, and the data sets were pooled to give a
mean mass of 277 MDa (Table 2 and Figure S2). From the mass,
an estimate of the total number of Gag proteins contained within
a particle can be derived using available information about the
stoichiometry of other known components that have been quan-
tified relative to Gag in previous studies (see Table S1 for details).
From this calculation, we estimate Gag to contribute slightly less
than 50% of total virus mass, corresponding to 133 MDa in these
preparations. This equals approximately 2400 copies of Gag and
is in excellent agreement with the calculation from the cryo-ET
measurements described above. Aliquots of the same prepara-
tions as analyzed by STEM were also imaged by cryo-EM, and a
mean particle radius of 66 nm was measured directly from the
images (Table 2). Based on the known packing density of Gag
(Briggs et al., 2004), approximately 3900 copies of Gag would be
required to form a completely closed Gag lattice within a particle
of this radius. The measured 2400 copies of Gag correspond to
61% of this number (Figure S2) or a closure of the Gag layer of
209 for these preparations.
Electron Tomography of HIV-1 Budding Sites
Next, we wanted to study the morphology of the cellular HIV-1
budding sites. Quantitative analysis of a sufficient number of such
structures is currently only feasible using sectioned material, and
we chose electron tomography of plastic embedded sections
for this part of the study to allow a higher throughput and more




group (n = 41)
Buds in budding-arrested
group (n = 27)
Radius (nm) 63 ± 5 75 ± 7 67 ± 5 (66 ± 5)
Closure (degrees) 229 ± 35 253 ± 73 306 ± 66 (328 ± 22)
Number of Gag molecules 2400 ± 700 4100 ± 1700 3600 ± 1100 (3800 ± 770)
Radius of curvature and Gag shell closure was measured for particles and for buds fully contained in the sections, and the number of Gag molecules
was calculated from these numbers and the known lattice constant (see Supplemental Data). For definition of release-competent and budding-
arrested groups, see Table 3. In the budding-arrested group, the numbers in parentheses indicate the values when the three budding sites that did
not have a late bud morphology (i.e., Gag closure >180) were discarded.evier Inc.
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Immature + PFA Mature + PFA Mature + 2AT Total
Cryo-EM radius (nm) 65 ± 17 (n = 150) 65 ± 8 (n = 150) 69 ± 16 (n = 150) 66 ± 17 (n = 450)
STEM radius (nm) 64 ± 16 (n = 84) 60 ± 18 (n = 162) 61 ± 17 (n = 96) 61 ± 17 (n = 342)
STEM HIV-1 mass (Mda) 319 ± 93 (n = 84) 292 ± 89 (n = 162) 304 ± 103 (n = 96) 302 ± 94 (n = 342)
STEM TMV mass (kDa/A˚) 14.86 ± 1.63 (n = 168) 14.06 ± 0.81 (n = 324) 14.11 ± 0.90 (n = 192) 14.27 ± 1.14 (n = 684)
Corrected STEM HIV-1 mass (Mda) 281 ± 82 (n = 84) 272 ± 83 (n = 162) 282 ± 96 (n = 96) 277 ± 86 (n = 342)
Immature and mature HIV-1 (NL4-3) particles were purified from infected MT-4 cells and inactivated with either PFA or 2AT. Size measurements by
cryo-EM were performed on the same virus preparations used for STEM. Since there was no significant change in mass or size due to the method
of inactivation or proteolytic maturation, these data were pooled to yield the numbers in the last column (total). The true TMV mass per length is
13.1 kDa/A˚, and the ratio of measured and true TMV mass was used for calibration to calculate the corrected HIV mass.performed on thick sections (300 nm nominal thickness) of fixed,
resin-embedded cells producing HIV-1. Thirty-six tilt series were
recorded, containing 145 budding sites in total, of which 68 were
fully contained within the section (i.e., not partially cut away in the
sectioning process). Producer cells were either MT-4 cells in-
fected with HIV-1 or HeLa cells transfected with the noninfectious
HIV-1 expression plasmid pDR (Gottwein and Kra¨usslich, 2005),
which contains all viral open reading frames and yields particles
morphologically indistinguishable from HIV-1. To induce a late-
budding arrest, we either used a pDR variant that does not recruit
ESCRT due to mutation of the PTAP motif (Gottwein and Kra¨us-
slich, 2005) or performed cotransfection of pDR with an expres-
sion vector for dominant-negative VPS4A (dnVPS4A) (von
Schwedler et al., 2003) (Table 3).
Figure 3 and Movie S4 show a representative tomogram from
a HeLa cell transfected with PTAP-deficient pDR. The tomogram
was recorded on an area of the plasma membrane with high bud-
ding activity. Such areas were often found to be clustered on
small parts of the cell surface, separated by larger areas where
no budding was detected. While the integrity of actin filaments
and other cytosolic components was compromised by the fixa-
tion and staining, membranes and Gag protein layers appeared
intact and well preserved. All HIV-1 budding sites contained a
single, continuous, membrane-apposed Gag layer. Since the to-
mograms used for quantitative analysis included the entire HIV-1-
specific structure, possible membrane continuity with the host
cell and the relative budding stage (early/late) could be unequiv-
ocally determined, avoiding the ambiguity present in studies of
thin sections. For example, Figures 3B–3F show computational
z sections through two parts of the tomogram in Figure 3A; Fig-
ure 3B clearly reveals a late HIV-1 bud, while the same structureCell Hostappears like a released, immature virion in the other sections (Fig-
ures 3C and 3D). Furthermore, this seemingly extracellular par-
ticle appears to be localized within an intracellular compartment
in Figure 3C, but this is unequivocally identified as invagination
of the plasma membrane in Figure 3D. A similar situation was
observed for the adjacent structure in the tomogram, where two
late buds protrude into a membrane invagination. In Figure 3A,
this appears as an immature particle within an intracellular com-
partment, but in the section displayed in Figure 3F, this particle
is identified as a membrane-connected late bud, and Figure 3E
reveals the continuity with the plasma membrane, along with the
second late-budding structure.
The stalk regions of the late buds were carefully examined for
potential differences, dependent on the construct(s) used for
transfection. According to theory, the PTAP-deficient Gag mole-
cules would be expected to be incapable of ESCRT recruitment,
while cotransfection of dnVPS4A might prevent disassembly of
ESCRT complexes at the budding site; however, no consistent
morphological difference between these two experimental con-
ditions could be identified at the resolution of the images ana-
lyzed in this study. Therefore, the tomograms were grouped as
release competent (HIV-1 infection or pDR transfection) and bud-
ding arrested (PTAP-deficient or dnVPS4A cotransfection), and
fully contained budding sites in each of these groups were pooled
for quantitative analysis (41 and 27 buds, respectively) (Table 3).
As described for the released particles, each fully contained
budding site was characterized by its radius of curvature and the
closure of the Gag layer (Table 1). Both early- and late-budding
structures were detected in the tomograms, providing a sequen-
tial three-dimensional view of this process (Figures 3G–3J). Plot-
ting radius of curvature against the degree of closure for theTable 3. Data Collected on Budding Sites in Resin-Embedded Sections
Virus or construct Cell type Number of tomograms Number of budding sites
Number of budding sites fully
contained within sections
HIV-1, strain NL-4-3 MT-4 cells 19 78 36
pDR HeLa 2 6 5
Total, release-compentent group 21 84 41
pDR-PTAP() HeLa 7 39 16
pDR + dnVPS4A HeLa 8 22 11
Total, budding-arrested group 15 61 27
The number of recorded tomograms is stated for each construct, along with the total number of budding sites in these tomograms, and the number of
budding sites that were fully contained within the sections, i.e., not sliced off in the sectioning. All data analysis was performed on this subset of fully
contained structures. See the Experimental Procedures section for details of data-collection parameters.& Microbe 4, 592–599, December 11, 2008 ª2008 Elsevier Inc. 595
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(A) A 2 nm thick computational slice through a tomogram of a HeLa cell expressing a budding-arrested (PTAP mutation) HIV-1 construct. The inset in the upper
right corner is a surface model of the two budding sites in the right part of the slice, with the membrane (cut open) in light blue and Gag in red. (A movie of the entire
tomogram is available as Movie S1).
(B–D) Slices through the tomogram at the position indicated by the left box in (A), at different z positions (82 nm, 61 nm, and 18 nm with respect to A,
respectively).
(E–F) Slices through the tomogram at the position indicated by the right box in (A), at 69 nm and +23 nm, respectively.
(G–J) Central slices through four of the fully contained budding sites in this tomogram, rotated so that the center of the Gag density points upwards. Scale bar is
100 nm.budding-arrested group (Figure 2D) revealed that the few early-
budding sites observed had a similar radius of curvature as the
nearly closed spheres. This indicates that the radius of curvature
is determined early in the budding process.
The 41 budding sites in the release-competent group showed
a broad distribution of closures from early-budding sites to
almost closed spheres (average closure 253) (Table 1 and Fig-
ure 2B). Further, they had a larger radius than both the arrested
buds and the released immature particles (Table 1). On the other
hand, the 27 budding sites comprising the budding-arrested
group exhibited a significantly more closed Gag shell than the
extracellular virions (Wilcoxon rank sum test, p = 7 3 107).
The arrested late-budding structures had a radius of 66 ± 5 nm,
similar to the immature particles, but an average closure of the
Gag layer of 330 (Figure 2C and Table 1). This corresponds
to 3800 Gag molecules in the arrested late-budding structures
for these preparations. To determine whether the opening in the596 Cell Host & Microbe 4, 592–599, December 11, 2008 ª2008 ElsGag layer detected in all HIV-1 budding sites analyzed could
have been caused by the fixation and embedding procedure,
we performed tomography of thick sections of cells expressing
a budding-arrested variant (PSAP deficient) of Mason-Pfizer
Monkey Virus (M-PMV) (Gottwein et al., 2003). M-PMV is a beta-
retrovirus whose Gag polyproteins assemble in the cytoplasm into
spherical procapsids, which are subsequently enveloped at the
plasma membrane. In this case, a completely closed spherical
Gag shell was observed for 10 of the 11 fully contained budding
sites in the tomograms (data not shown), thus indicating that
the incomplete Gag shells detected in the case of HIV-1 were
not the result of sample preparation.
DISCUSSION
Combining structural studies on cellular HIV-1 budding sites with
structural data and mass measurements of released virions, weevier Inc.
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the budding site and how this is linked to viral release. The results
of this three-dimensional quantitative study of HIV-1 morpho-
genesis yield a refined quantitative estimate for virion composi-
tion and suggest that HIV-1 release results from concerted rather
than sequential action of Gag and ESCRT.
Our tomographic analysis of immature HIV-1 particles con-
firms the recent findings by Wright et al. (Wright et al., 2007),
who reported that the Gag lattice is incomplete. We found, how-
ever, that Gag molecules arrange as a continuous truncated
sphere, typically covering approximately two-thirds of the viral
membrane, while Wright et al. reported 40% coverage and
a patchy distribution of ordered Gag segments. Incompleteness
of the Gag lattice in the immature virion could be due either to
budding of the virus before the Gag shell is closed or to partial
disassembly of the Gag shell after release. The two possibilities
can be distinguished by mass determination, since disassembled
Gag molecules would remain enclosed in the extracellular virion.
STEM analysis of individual freeze-dried HIV-1 particles revealed
virtually identical masses for immature and mature virions, corre-
sponding to a Gag membrane coverage of61% and an average
of 2400 Gag molecules per virion (with an average radius of 66
nm). The close correspondence of these measurements with
the cryo-ET data shows that postrelease disassembly cannot
be the reason for the incomplete immature Gag lattice.
Given that the 70% Gag coverage derived from our cryo-ET
measurements is consistent with that from STEM-based mass
determination, it appears likely that the lower coverage observed
by Wright et al. is due to experimental differences and the mea-
surement of different properties. Whereas we have manually
fitted a truncated sphere model to the part of the membrane cov-
ered by Gag density, Wright et al. imposed the stricter criterion
of density with local six-fold symmetry. Given the noisy recon-
structions of cryo-ET, this criterion can be expected to yield
a lower coverage. Second, Wright et al. used noninfectious
HIV-1 particles purified from 293T cells, while we have analyzed
inactivated (and thereby briefly fixed) HIV-1 from MT-4 cells.
Both the PFA fixation as well as differences in the lipid composi-
tion of the viral envelope dependent on the producer cell (B.G.
and H.-G.K., unpublished data) may have increased the stability
of the Gag lattice in our case. A less stable lattice resulting in par-
tial disassembly during sample preparation could also explain the
patchy appearance of the Gag lattice described by Wright et al.
It should be noted that an incomplete Gag layer and the result-
ing lower Gag stoichiometry are more compatible with previous
biochemical measurements than the large number of Gag mole-
cules required to form a complete shell. Incompleteness of the
lattice was not detected in the previous study because of inher-
ent limitations of projection images, and in vitro-assembled par-
ticles were used as a proxy for the Gag shell in the virion (Briggs
et al., 2004). More recent three-dimensional analysis of such
in vitro-assembled particles confirmed that they are more com-
plete than immature virus particles (data not shown), thus vali-
dating the previously reported stoichiometry for these particles.
One should also emphasize that the revised number of Gag mol-
ecules is still double the 1200–1500 CA molecules needed for
formation of the mature cone-shaped capsid shell (Briggs
et al., 2003). This corresponds well to results of the hydrogen-
deuterium exchange experiment, which indicated that 50%Cell Hostof CA in the mature virion shows rapid exchange and may thus
not be part of the capsid shell (Lanman et al., 2004). Furthermore,
the copy numbers of other virion constituents (current estimates
summarized in Swanson and Malim [2008]) need to be revised
based on these results, since they are generally defined in relation
to Gag. As already stated for Gag, these numbers are dependent
on virion size, which is highly variable in the case of HIV-1, and we
therefore provide estimates for different virion diameters in Table
S1. Virions with a radius of 66 nm (or 73 nm) and a 61% complete
Gag shell would thus contain340 (420) molecules of Vpr (1:7)
(Mu¨ller et al., 2000),240 (300) molecules of cyclophilin A (1:10)
(Franke et al., 1994), and120 (150) molecules of integrase and
reverse transcriptase (1:20) (Welker et al., 1996) (see Table S1).
The result that the Gag shell in released immature HIV-1 is only
approximately two-thirds closed already indicates that the well-
described late-budding structures displaying ‘‘lollipop’’ mor-
phology may not be direct precursors of the extracellular virus.
This was confirmed by quantitative three-dimensional analysis of
budding-arrested structures. Their Gag layers were almost com-
pletely closed, independent of whether release was blocked by
mutations in Gag preventing recruitment of ESCRT or mutations
in VPS4A preventing ESCRT disassembly and recycling. Thus,
the so-called late-budding structure contains many more Gag
molecules than the released virus and can therefore not be an
intermediate in HIV-1 morphogenesis. The almost complete
spherical Gag shell found in in vitro-assembled particles and
arrested budding sites may represent the equilibrium geometry,
which is reached due to a prolonged lifetime of arrested or dead-
end structures at the membrane. Consequently, wild-type HIV-1
release must occur before the assemblage reaches its steady
state geometry, most likely by action of the ESCRT machinery.
Notably, budding sites in the release-competent group exhibited
a different geometry from both budding-arrested structures and
released immature virions. Their Gag layers were found in
a broader continuum of states, with many buds having a more
closed Gag shell than the immature virions. This, combined
with their slightly larger average radius, prompts us to speculate
that those ‘‘wild-type’’ budding structures observed by EM
(with a calculated average Gag content of 4100 molecules)
may represent a mixture of productive budding events and
a class of delayed budding structures that are not part of the pro-
ductive release pathway.
The current model of HIV-1 morphogenesis suggests that an
almost closed spherical Gag shell assembles at the plasma mem-
brane concomitant with induction of curvature (budding). The re-
sultant structure is thought to be connected to the cell by a thin
membrane tether, which is subsequently severed by the ESCRT
machinery (abscission; Figure 4A). The results of this study indi-
cate that the model needs to be revised and that release is trig-
gered by the ESCRT machinery much earlier in the budding pro-
cess. The average diameter of the membrane at the rim of the
Gag layer in the released immature virus preparation was 109 ±
19 nm, compared to only 36 ± 21 nm in the arrested buds. We
therefore speculate that ESCRT functions by closing the bulged
membrane early in the budding process (Figure 4B) rather than
pinching off a ‘‘ready-made virus’’ (Figure 4A). ESCRT function
in HIV-1 release is thus more similar than previously thought to
its role in cellular vesicle formation where ESCRT is involved in all
stages of sorting and vesiculation and is clearly not limited to the& Microbe 4, 592–599, December 11, 2008 ª2008 Elsevier Inc. 597
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is also tempting to speculate that the accessible rim of the incom-
plete Gag layer in the immature virus is the site where proteolytic
cleavage of Gag and maturation commences.
According to the revised model of HIV-1 morphogenesis, Gag
recruits ESCRT-I, and consequently ESCRT-III, in a PTAP-de-
pendent manner to the emerging viral bud; and ESCRT-III, in
conjunction with VPS4, serves to constrict the wide membrane
rim induced by Gag assembly. Thus, ESCRT-mediated release
would occur concomitant—and in kinetic competition—with Gag
assembly. The revised model suggests that ESCRT-III contrib-
utes to membrane bending to complete the budding process,
while Gag assembly drives early budding. This role of ESCRT
is consistent with the recently solved structure of the ESCRT-III
component CHMP3 (Muziol et al., 2006) and supported by two
recent studies of the mechanism of ESCRT-III. The first of these
reported plasma membrane deformation by ESCRT-III, showing
that overexpression of CHMP4A/B together with inactive VPS4B
induced bending of the plasma membrane away from the cyto-
plasm to form buds and tubules protruding from the cell surface
(Hanson et al., 2008). The second study reported that CHMP2A
and CHMP3 form helical tubes in vitro, with the membrane-bind-
ing sites facing the outside (Lata et al., 2008). These tubes could
be disassembled by the action of VPS4. A similar membrane-
bending function could be envisioned in virus release to complete
the budding process. The principle of virus budding proposed for
HIV-1 in this report may also apply to other viral systems.
EXPERIMENTAL PROCEDURES
Sample Preparation
HeLa and MT-4 cells were maintained in DMEM and RPMI-1640, respectively,
and supplemented with 10% fetal calf serum and antibiotics. Transfections
Figure 4. Two Alternative Models for HIV-1
Assembly and Release
(A) HIV-1 release occurs after complete assembly
of the Gag shell.
(B) Release occurs concomitant with formation
of the Gag shell by simultaneous assembly and
ESCRT-mediated vesiculation, as suggested by
this study.
were performed using the calcium phosphate
method or FuGENE 6 (Roche). The HIV-1 proviral
plasmid pNL4-3 (Adachi et al., 1986), plasmids
pDR and its PTAP-deficient variant (Gottwein
and Kra¨usslich, 2005), as well as the expression
plasmid for dnVPS4A have been described. The
expression plasmid for dnVPS4A was a kind gift
of W.I. Sundquist, University of Utah (von Schwe-
dler et al., 2003). Infection of MT-4 cells with HIV-1
strain NL43 by coculture and purification of the vi-
rus from tissue culture supernatant by Iodixanol
gradient centrifugation was performed as de-
scribed (Welker et al., 2000), and the same purifi-
cation protocol was used for virus from trans-
fected HeLa cells. Immature particles were
obtained by adding a specific HIV protease inhib-
itor (either lopinavir at a concentration of 2 mM or saquinavir at a concentration
of 5 mM) 6 hr after infection. Samples for cryo-ET or STEM were inactivated
using PFA or 2-AT as previously described (Rossio et al., 1998). Samples for
electron tomography were fixed and EPON-embedded using standard
procedures.
Transmission Electron Microscopy
Data were recorded using a Philips CM300 or a FEI Tecnai F30 Polara trans-
mission electron microscope (FEI; Eindhoven, The Netherlands), both equip-
ped with 300 kV field emission guns; Gatan GIF 2002 Post-Column Energy
Filters; and 2k3 2k Multiscan CCD Cameras (Gatan; Pleasanton, CA). All data
collection was performed at 300 kV, with the energy filter operated in the zero-
loss mode. Cryotilt series were typically recorded from 63 to +63 with an
angular increment of 3. The total dose was between 45 and 70 electrons
A˚2. The defocus was between 4.5 and 5.5 mm. For the cryotilt series,
the pixel size at the FEI Tecnai F30 Polara was 0.49 nm at the specimen level.
Cellular tilt series were typically recorded from65 to +65, with an increment
of 1.0 and defocus of3 to4 mm. For the cellular tilt series, the pixel sizes at
the specimen level were 0.821 and 0.805 nm at the Philips CM300 and the FEI
Tecnai F30 Polara, respectively.
STEM Mass Measurements
STEM was carried out essentially as described in Vogt and Simon, 1999. TMV
as a control with known mass per length was included in all samples for cali-
bration. For each HIV-1 particle analyzed, we measured the mass/A˚ of two
segments of TMV from the same image. There was no clear correlation
between TMV mass/A˚ and the mass of the virus particle from the same image.
The corrected virus mass was therefore calculated by dividing by the TMV
mass/A˚ for the data set and multiplying by the known mass/A˚ (13.1 kDaA˚1).
The error in the estimate of the mean of the TMV mass/A˚ was considered to
be small compared to the variation in HIV-1 virus particle mass. The mass/A˚
of TMV for the complete pooled data set was 14.3 ± 1.1 kDa/A˚ (n = 684).
The contribution of different virion constituents to total HIV-1 mass was esti-
mated based on published reports, where relative amounts of different com-
ponents were estimated in relation to the HIV-1 CA protein, and this calculation
is shown in Table S1.598 Cell Host & Microbe 4, 592–599, December 11, 2008 ª2008 Elsevier Inc.
Cell Host & Microbe
A Revised Model for HIV-1 MorphogenesisData Analysis
Three-dimensional reconstructions from tilt series were performed with the
weighted back-projection method, using the TOM toolbox (Nickell et al., 2005)
for MATLAB (Mathworks; Natick, MA) or IMOD (Kremer et al., 1996). Further
analysis of the tomograms was done using the TOM toolbox and SPIDER
(Frank et al., 1996). Briefly, the Gag shell closures were estimated by trans-
forming the extracted subvolumes—containing single virions or budding
sites—to spherical polar coordinates and estimating the extent of the Gag
layer in this representation, whereas the radii were measured by locating the
membrane peak in a radial density plot (see Supplemental Experimental Pro-
cedures). Visualizations of the tomograms were done with Amira (http://www.
amiravis.com).
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures, Sup-
plemental References, two figures, one table, and four movies, and can
be found online at http://www.cell.com/cellhostandmicrobe/supplemental/
S1931-3128(08)00367-3.
ACKNOWLEDGMENTS
We are grateful to V. Vogt, M. Lehmann, and S. Ja¨ger for help with some of the
experiments and to S. Prinz, A. Habermann, H. Oberwinkler, and B.Y. Lin for
technical assistance. This work was supported by grants from the Deutsche
Forschungsgemeinschaft within SPP1175 to H.-G.K and to K.G. The BNL
STEM facility was an NIH-supported resource center, NIH 5 P41 EB2181,
with additional support provided by DOE, OBER.
Received: June 13, 2008
Revised: September 5, 2008
Accepted: October 2, 2008
Published: December 10, 2008
REFERENCES
Adachi, A., Gendelman, H.E., Koenig, S., Folks, T., Willey, R., Rabson, A., and
Martin, M.A. (1986). Production of acquired immunodeficiency syndrome-
associated retrovirus in human and nonhuman cells transfected with an infec-
tious molecular clone. J. Virol. 59, 284–291.
Adamson, C.S., and Freed, E.O. (2007). Human immunodeficiency virus type 1
assembly, release, and maturation. Adv. Pharmacol. 55, 347–387.
Briggs, J.A.G., Wilk, T., Welker, R., Kra¨usslich, H.G., and Fuller, S.D. (2003).
Structural organization of authentic, mature HIV-1 virions and cores. EMBO
J. 22, 1707–1715.
Briggs, J.A.G., Simon, M.N., Gross, I., Kra¨usslich, H.G., Fuller, S.D., Vogt,
V.M., and Johnson, M.C. (2004). The stoichiometry of Gag protein in HIV-1.
Nat. Struct. Mol. Biol. 11, 672–675.
Demirov, D.G., and Freed, E.O. (2004). Retrovirus budding. Virus Res. 106,
87–102.
Frank, J., Radermacher, M., Penczek, P., Zhu, J., Li, Y.H., Ladjadj, M., and
Leith, A. (1996). SPIDER and WEB: Processing and visualization of images in
3D electron microscopy and related fields. J. Struct. Biol. 116, 190–199.
Franke, E.K., Yuan, H.E., and Luban, J. (1994). Specific incorporation of cyclo-
philin A into HIV-1 virions. Nature 372, 359–362.
Gottwein, E., and Kra¨usslich, H.G. (2005). Analysis of human immunodefi-
ciency virus type 1 Gag ubiquitination. J. Virol. 79, 9134–9144.
Gottwein, E., Bodem, J., Mu¨ller, B., Schmechel, A., Zentgraf, H., and Kra¨us-
slich, H.G. (2003). The Mason-Pfizer monkey virus PPPY and PSAP motifs
both contribute to virus release. J. Virol. 77, 9474–9485.Cell HostHanson, P.I., Roth, R., Lin, Y., and Heuser, J.E. (2008). Plasma membrane
deformation by circular arrays of ESCRT-III protein filaments. J. Cell Biol.
180, 389–402.
Hurley, J.H. (2008). ESCRT complexes and the biogenesis of multivesicular
bodies. Curr. Opin. Cell Biol. 20, 4–11.
Kremer, J.R., Mastronarde, D.N., and McIntosh, J.R. (1996). Computer visual-
ization of three-dimensional image data using IMOD. J. Struct. Biol. 116,
71–76.
Lanman, J., Lam, T.T., Emmett, M.R., Marshall, A.G., Sakalian, M., and Preve-
lige, P.E., Jr. (2004). Key interactions in HIV-1 maturation identified by hydro-
gen-deuterium exchange. Nat. Struct. Mol. Biol. 11, 676–677.
Lata, S., Schoehn, G., Jain, A., Pires, R., Piehler, J., Go¨ttlinger, H.G., and Weis-
senhorn, W. (2008). Helical Structures of ESCRT-III Are Disassembled by
VPS4. Science 321, 1354–1357.
Lucic´, V., Fo¨rster, F., and Baumeister, W. (2005). Structural studies by electron
tomography: from cells to molecules. Annu. Rev. Biochem. 74, 833–865.
Morita, E., and Sundquist, W.I. (2004). Retrovirus budding. Annu. Rev. Cell
Dev. Biol. 20, 395–425.
Mu¨ller, B., Tessmer, U., Schubert, U., and Kra¨usslich, H.G. (2000). Human
immunodeficiency virus type 1 Vpr protein is incorporated into the virion in sig-
nificantly smaller amounts than gag and is phosphorylated in infected cells. J.
Virol. 74, 9727–9731.
Muziol, T., Pineda-Molina, E., Ravelli, R.B., Zamborlini, A., Usami, Y., Gottlin-
ger, H., and Weissenhorn, W. (2006). Structural basis for budding by the
ESCRT-III factor CHMP3. Dev. Cell 10, 821–830.
Nickell, S., Fo¨rster, F., Linaroudis, A., Del Net, W., Beek, F., Hegerl, R., Bau-
meister, W., and Plitzko, J.M. (2005). TOM software toolbox: acquisition and
analysis for electron tomography. J. Struct. Biol. 149, 227–234.
Rossio, J.L., Esser, M.T., Suryanarayana, K., Schneider, D.K., Bess, J.W., Vas-
quez, G.M., Wiltrout, T.A., Chertova, E., Grimes, M.K., Sattentau, Q., et al.
(1998). Inactivation of human immunodeficiency virus type 1 infectivity with
preservation of conformational and functional integrity of virion surface pro-
teins. J. Virol. 72, 7992–8001.
Swanson, C.M., and Malim, M.H. (2008). SnapShot: HIV-1 proteins. Cell 133,
742.
Vogt, V.M., and Simon, M.N. (1999). Mass determination of Rous sarcoma
virus virions by scanning transmission electron microscopy. J. Virol. 73,
7050–7055.
von Schwedler, U.K., Stray, K.M., Garrus, J.E., and Sundquist, W.I. (2003).
Functional surfaces of the human immunodeficiency virus type 1 capsid pro-
tein. J. Virol. 77, 5439–5450.
Wall, J.S., Hainfeld, J.F., and Simon, M.N. (1998). Scanning transmission elec-
tron microscopy of nuclear structures. Methods Cell Biol. 53, 139–164.
Welker, R., Kotler, H., Kalbitzer, H.R., and Kra¨usslich, H.G. (1996). Human
immunodeficiency virus type 1 Nef protein is incorporated into virus particles
and specifically cleaved by the viral proteinase. Virology 219, 228–236.
Welker, R., Hohenberg, H., Tessmer, U., Huckhagel, C., and Kra¨usslich, H.G.
(2000). Biochemical and structural analysis of isolated mature cores of human
immunodeficiency virus type 1. J. Virol. 74, 1168–1177.
Williams, R.L., and Urbe, S. (2007). The emerging shape of the ESCRT machin-
ery. Nat. Rev. Mol. Cell Biol. 8, 355–368.
Wright, E.R., Schooler, J.B., Ding, H.J., Kieffer, C., Fillmore, C., Sundquist,
W.I., and Jensen, G.J. (2007). Electron cryotomography of immature HIV-1 vi-
rions reveals the structure of the CA and SP1 Gag shells. EMBO J. 26, 2218–
2226.& Microbe 4, 592–599, December 11, 2008 ª2008 Elsevier Inc. 599
